Venus Remedies Limited has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 26, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 15, 2026, was submitted to both the National Stock Exchange of India Ltd. and BSE Limited.

Board Meeting Agenda

The board meeting has been convened to address several key matters. The following items are on the agenda for consideration:

Trading Window Closure

In compliance with the provisions of Prevention of Insider Trading, Venus Remedies has closed the trading window for designated persons with respect to trading in the company's shares. The closure is effective from April 1, 2026, and will remain in force until 48 hours after the declaration of the financial results. This measure is intended to ensure that designated persons do not trade in company securities while in possession of unpublished price-sensitive information.

The intimation has also been uploaded on the company's official website at www.venusremedies.com . The filing was digitally signed on May 15, 2026.

Venus Remedies Limited has issued a formal communication to shareholders, announcing the opening of a special window for the re-lodgement of transfer requests for physical shares. The company subsequently filed a newspaper publication notice dated May 5, 2026, with both the National Stock Exchange of India Ltd. and BSE Limited, in compliance with applicable regulatory requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Basis for the Announcement

The special window has been opened in accordance with SEBI Circular No. HO/38/13/11/2026-MIRSD-POD/13750/2026, issued on January 30, 2026. As per the circular, the special window is open from February 05, 2026 to February 04, 2027, for re-lodgement of transfer deeds that were lodged before April 1, 2019 but were rejected, returned, or left unattended due to deficiency in documents, process, or otherwise. All such securities will be transferred only in demat form after due process as outlined in the SEBI circular.

Notice to Shareholders

Venus Remedies has advised shareholders who have not yet converted their eligible physical shares to utilise this final opportunity. Shareholders are required to submit requests along with requisite documents and original share certificates to the Company's Registrar and Transfer Agent (RTA). The RTA contact details are as follows:

Social Media Dissemination

Venus Remedies also disseminated the shareholder notice through its official social media platforms to ensure broad shareholder reach and transparency. The following table summarises the platforms used for this communication:

Company Details

The newspaper publication notice was signed by the Company Secretary and digitally authenticated on May 5, 2026. The initial shareholder communication was signed and authenticated on May 4, 2026. Key corporate details of Venus Remedies Limited are as follows:

Venus Remedies has requested both exchanges to take the above communication on record.

Source: None/Company/INE411B01019/01d58e000e684a1d.pdf